Lincoln Park, NJ, United States of America

Piotr “Peter” H Karpinski

This inventor holds 3 USPTO granted patents. Top assignees: Novartis Ag, Novartis Pharma Gmbh. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Piotr “Peter” H Karpinski. Retrieved from https://idiyas.com/inventor/piotr-peter-h-karpinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 31(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2013-2014

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8829015 - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide (2014-09-09),

2. 8415363 - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide (2013-04-09),

3. 8343984 - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide (2013-01-01),

Title: Piotr “Peter” H Karpinski: Innovator in Pharmaceutical Chemistry

Introduction

Piotr “Peter” H Karpinski is a notable inventor based in Lincoln Park, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on the development of crystalline forms of various chemical compounds.

Latest Patents

Karpinski's latest patents include innovative formulations such as "Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide" and its free base and salts. These formulations are prepared through various processes, showcasing his expertise in creating effective pharmaceutical compounds.

Career Highlights

Throughout his career, Karpinski has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Karpinski has collaborated with esteemed colleagues such as Paul William Manley and Wen-Chung Shieh. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Piotr “Peter” H Karpinski is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and collaborations. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]